Where technology meets life
Leverage biological information to offer personalized therapies: imagine medical treatment customized according to your genetic makeup, health history, gender or even lifestyle!
Our combination of engineering skills, biological understanding and cutting-edge infrastructure enables us to push the boundaries of life sciences technologies. We bridge disciplines from precision manufacturing to digitalization to develop disruptive biosystems by bringing the patient-in-the-lab and the lab-on-the-patient. From design to technology biovalidation in our biosafety level 2 laboratories, we use the latest advances in cell microsystems, biomonitoring, and lab automation.
Bioconvergence—a dynamic integration of biotechnology, engineering, and computing—is transforming the life sciences by addressing complex challenges. This interdisciplinary field is revolutionizing diagnostics, materials development, pharmaceuticals, and sustainable agriculture. Find out how CSEM applies bioconvergence in its projects, accelerating transformation for the benefit of clients and partners.
Our solutions bring together emerging micro-technologies and the biotech/pharma industries to narrow the gap between applied sciences and industrialization.
We offer our expertise to help you bring your microfluidic solutions to life—ensuring reliability, precision, and high quality.
Microfluidics and MEMS technology
3D printed biosensors
From concept to prototyping, including small series production and manufacturability, we help the life sciences industry to develop new products used in drug testing, tissue engineering, lab of the future and point-of-care diagnostics.
Get in touch to find out how you can get more out of life sciences today.
Working with CSEM has been excellent. Developing a MEMS device requires not only the right facilities and equipment, but an extremely knowledgeable team with microfabrication processes ready to go.
CSEM provides a complete spectrum of expertise and its multidisciplinary teams are so used to finding practical solutions and managing innovation projects that they act as the glue between all the different stages of the project.
INVENesis provides services for drug discovery to industrial partners in animal health, pharmaceutics, and crop protection. Working with CSEM allowed us to develop a motility trap assay (MTA) for the automated high-throughput screening of drug candidates on parasitic nematodes by assessing their behavioral phenotypes.
It was a great pleasure and extremely rewarding to work with CSEM on the development of the first automated human skeletal muscle microphysiological lab system, which screens for the drug compounds that regulate muscle functions, such as force and fatigue.
In addition to its technical skills, CSEM had the advantage of being familiar with the required multidisciplinary approach and has a solid experience in production process engineering.
Working with CSEM allowed us to develop and jointly validate a new diagnostic microarray/ sensor device designed for use in low-resource settings. To better promote point of care solutions for everyday life, synergistic partnerships between health experts and technology providers are both mutually beneficial and highly relevant.
The MEDILIGHT partners have shown the potential of blue light in patient care – and the story is just beginning.
In the fast-paced field of high-power femtosecond lasers for industrial applications, NKT Photonics teamed up with CSEM to develop a cutting-edge technology. Thanks to the dedication and the good communication within the team, all the objectives have been reached and the technology is now implemented in our commercial systems.
Working with CSEM is incredibly helpful because they are outside your business and yet focused on exactly the same problems.
CSEM’s technology has given us a unique platform for drinking water monitoring and also for industrial, food and beverage, and pharmaceutical applications.
3 June 2026
Hamilton’s GlucoSense enables real-time bioreactor glucose monitoring, helping biologics manufacturers improve process control and bioprocessing performance with CSEM support.
3 September 2025
cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million patients annually in Europe and the USA.
18 March 2025
400 experts discussed how to take advantage of the new global trend of bioconvergence, in which all disciplines work together – from biology to engineering to digitalization.